Abiopharma

Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer

Emergent BioSolutions Supports Victorias Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people

Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting

LyondellBasell tritt in eine Vereinbarung und exklusive Verhandlungen mit AEQUITA über den Verkauf von vier europäischen Vermögenswerten im Rahmen der strategischen Bewertung ein

LyondellBasell enters into an agreement and exclusive negotiations with AEQUITA for the sale of four European Strategic Assessment assets

LyondellBasell llega a un acuerdo y negociaciones exclusivas con AEQUITA para la venta de los cuatro activos incluidos en la evaluación estratégica europea

LyondellBasell conclut un accord et entame des négociations exclusives avec AEQUITA pour la vente de quatre actifs issus de son évaluation stratégique européenne